Durvalumab Combined With Pemetrexed-Based Chemotherapy in Trial-Ineligible Patients With Mesothelioma: A Brief Report by Ibiayi Dagogo-Jack, MD, Aubrey Lasko, PharmD, Elizabeth A. Krueger, NP, Kitman Tsang, NP, Revati Rao, MD, Grace Hambelton, BA, Subba R. Digumarthy, MD

Get full text